Nevertheless, mGluR1, mGluR5, and microglia cells are indeed a promising target for ALS treatment and other neurodegenerative diseases in which neuroinflammation plays a pivotal role [73,90,92,270]. This evidence concerns the gene GRM1 and amyotrophic lateral sclerosis.